This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Conney, A. H. Search for Related Content PubMed PubMed Citation Articles by Conney, A. H.

Enzyme Induction and Dietary Chemicals as Approaches to Cancer Chemoprevention: The Seventh DeWitt S. Goodman Lecture¹

Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854-8020

Research on cancer chemoprevention is an important approach for decreasing both the incidence and number of deaths from cancer. The use of tamoxifen to prevent breast cancer, finasteride to prevent prostate cancer, and aspirin to prevent colon cancer are recent examples of cancer chemoprevention. This article describes research from my laboratory and related research from other laboratories on the effects of enzyme induction on chemical carcinogenesis as an approach to cancer chemoprevention, as well as studies on the inhibitory effects of curcumin, caffeine, (-)-epigallocatechin gallate (EGCG), and tea in animal models of carcinogenesis. The later substances appear to work, at least in part, by enhancing apoptosis in DNA-damaged cells or in tumors. The results of our studies and those of others provide a rationale for clinical trials on the potential chemopreventive effects of curcumin, caffeine, EGCG, and tea on the formation of cancer of the skin, mouth, esophagus, stomach, and colon in people with precancerous lesions and a high risk of developing these cancers.

It was pointed out that several compounds that are effective cancer chemopreventive agents in one experimental setting can enhance carcinogenesis in another experimental setting. These results suggest that it may be necessary to tailor the cancer chemopreventive regimen to individual subjects with known carcinogen exposures or to high cancer risk individuals with mechanistically understood pathways of carcinogenesis so that chemopreventive agents with known mechanisms of action can be better customized to the individual and selected on a more rational basis.

This article has been cited by other articles:

				S. R. Kondraganti, W. Jiang, A. K. Jaiswal, and B. Moorthy Persistent Induction of Hepatic and Pulmonary Phase II Enzymes by 3-Methylcholanthrene in Rats Toxicol. Sci., April 1, 2008; 102(2): 337 - 344. [Abstract] [Full Text] [PDF]

				R. Beliveau and D. Gingras Role of nutrition in preventing cancer Can Fam Physician, November 1, 2007; 53(11): 1905 - 1911. [Abstract] [Full Text] [PDF]

				A. B. Okey An Aryl Hydrocarbon Receptor Odyssey to the Shores of Toxicology: The Deichmann Lecture, International Congress of Toxicology-XI Toxicol. Sci., July 1, 2007; 98(1): 5 - 38. [Abstract] [Full Text] [PDF]

				C. S. Yang Dietary Factors May Modify Cancer Risk by Altering Xenobiotic Metabolism and Many Other Mechanisms J. Nutr., October 1, 2006; 136(10): 2685S - 2686S. [Full Text] [PDF]

				B. Paul, C. S. Hayes, A. Kim, M. Athar, and S. K. Gilmour Elevated polyamines lead to selective induction of apoptosis and inhibition of tumorigenesis by (-)-epigallocatechin-3-gallate (EGCG) in ODC/Ras transgenic mice Carcinogenesis, January 1, 2005; 26(1): 119 - 124. [Abstract] [Full Text] [PDF]

				R. Munday and C. M. Munday Induction of phase II enzymes by 3H-1,2-dithiole-3-thione: dose-response study in rats Carcinogenesis, September 1, 2004; 25(9): 1721 - 1725. [Abstract] [Full Text] [PDF]

				D. W. Nebert, T. P. Dalton, A. B. Okey, and F. J. Gonzalez Role of Aryl Hydrocarbon Receptor-mediated Induction of the CYP1 Enzymes in Environmental Toxicity and Cancer J. Biol. Chem., June 4, 2004; 279(23): 23847 - 23850. [Abstract] [Full Text] [PDF]

				M. Nagai, A. H. Conney, and B. T. Zhu STRONG INHIBITORY EFFECTS OF COMMON TEA CATECHINS AND BIOFLAVONOIDS ON THE O-METHYLATION OF CATECHOL ESTROGENS CATALYZED BY HUMAN LIVER CYTOSOLIC CATECHOL-O-METHYLTRANSFERASE Drug Metab. Dispos., May 1, 2004; 32(5): 497 - 504. [Abstract] [Full Text] [PDF]